F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers.

@article{Haug2007F18fluoro2deoxyglucosePE,
  title={F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers.},
  author={Alexander R Haug and Gerwin Paul Schmidt and Annemarie Klingenstein and Volker Heinemann and Petra Stieber and Markus Priebe and Christian la Foug{\'e}re and Christoph Becker and Klaus Hahn and Reinhold Tiling},
  journal={Journal of computer assisted tomography},
  year={2007},
  volume={31 4},
  pages={629-34}
}
OBJECTIVE The value of combined positron emission tomography (PET)/computed tomography (CT) in the follow-up of patients with breast cancer with elevated tumor markers but without proven metastases or local recurrence was assessed. METHODS Thirty-four women underwent PET/CT. The PET and CT images were first analyzed separately; fused findings were then interpreted, blinded to the results of the other modalities. The results of CT, PET, and PET/CT were compared with each other and correlated… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 2016

Similar Papers

Loading similar papers…